# Kegg

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kegg

- Industry: Medical Devices & Equipment
- Headquarters: San Francisco, US
- Website: www.kegg.tech/
- Total disclosed funding: $4.5M
- Latest round: Seed (Sep 1, 2021)
- Investors on record: 8

## About

Kegg is a US-based company specializing in medical-grade fertility tracking solutions, offering insights into female fertility by analyzing cervical fluid, thus supporting family planning efforts for women.Founded in 2017 and headquartered in San Francisco, US, Kegg focuses on empowering women with fertility tracking technology. The company has engaged in 7 investment deals and recently raised USD 6.5 mn in Series A funding led by Relentless Consumer Partners, marking its total amount raised at USD 6.5 mn and current valuation at USD 22.118 mn. Kristina Cahojova serves as both the CEO and founder.Kegg® provides a medical-grade fertility tracking device that delivers accurate insights into female fertility through the analysis of cervical fluid. This device, requiring only two minutes of daily use, helps women pinpoint their most fertile days by detecting changes in cervical mucus, essential for sperm survival and fertilization. Additionally, Kegg® includes guided Kegel exercises to enhance pelvic floor health, facilitating labor and postpartum recovery. The product is tailored for women facing various fertility challenges, including those with PCOS and irregular cycles, and has reached over 60,000 couples across North America and Europe.Kegg® operates on a direct-to-consumer model, generating revenue primarily through the sale of its flagship fertility tracking device, priced at USD 269. Customers can purchase the device via the company’s website, which also offers related services like guided Kegel routines. The revenue model is transactional, emphasizing one-time purchases rather than subscriptions, ensuring a seamless buying experience. The unique features and scientifically-supported approach of the device cater to increasing interests in family planning and reproductive health.In January 2025, Kegg raised USD 6.5 mn in Series A funding, which will be utilized to advance research and development on cervical mucus and associated vaginal health markers. The company aims to introduce new products to further enhance its offerings and is actively seeking to expand into additional markets in North America and Europe.

## Funding rounds

- Seed, Sep 1, 2021, $3M — AdAstra, Althea Capital, SOSV, Crescent Ridge, Texas Halo Fund, Viento Ventures
- Seed, Jul 22, 2021 — SOSV
- Seed, Oct 13, 2020, $1.5M — SOSV, Crescent Ridge, Texas Halo Fund, fermata, Megaforce Corporation Inc.
- Seed, Oct 10, 2017 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- Crescent Ridge (https://capitalatlas.ai/funds/crescent-ridge) — Seed
- Texas Halo Fund (https://capitalatlas.ai/funds/texas-halo-fund) — Seed
- fermata (https://capitalatlas.ai/funds/fermata) — Seed
- Megaforce Corporation Inc. — Seed
- AdAstra (https://capitalatlas.ai/funds/adastra) — Seed
- Althea Capital — Seed
- Viento Ventures (https://capitalatlas.ai/funds/viento-ventures) — Seed